|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Vidofludimus>> Market Analysis Reports |
Market Analysis Reports of Vidofludimus |
|
Primary Sclerosing Cholangitis– Pipeline Insight, 2020 ... -838 is a small molecule investigational drug (vidofludimus calcium) under development as an oral tablet ... , thereby reducing inflammation. In preclinical studies of vidofludimus, the active moiety and free ... 2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , Vazegepant , Velpatasvir, Veru-111, Videsil, Vidofludimus calcium, Virazole, VPM1002, XAV-19, XC221 ... COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , Vazegepant , Velpatasvir, Veru-111, Videsil, Vidofludimus calcium, Virazole, VPM1002, XAV-19, XC221 ... Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangitis - Drugs ... |